Novavax initiated phase 1/2 clinical trial of COVID-19 vaccine
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
-
-
The FDA approved only drug in the U.S. to treat severe malaria
On May 26, 2020, the U.S. Food and Drug Administration (FDA) approved artesunate for injection to treat severe…
-
Montefiore and Einstein tested new drug combination to conquer COVID-19
On May 26, 2020, Montefiore Health System and Albert Einstein College of Medicine announced they have begun the…
-
Meridian Bioscience supply reagents for manufacturing of tens of millions of COVID-19 antibody tests per month
On May 26, 2020, Meridian Bioscience announced that its SARS-CoV-2 antigens and related reagents are part of assays…
-
Rice University COVID-19 research fund awarded final grants
On May 26, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had awarded…
-
Analysis of COVID-19 genomes revealed large numbers of introductions to the UK in March, 2020
On May 22, 2020, data reports, published by the COVID-19 Genomics UK Consortium (COG-UK), showed the value in…
-
CIRM board expanded efforts of COVID-19 program
On May 22, 2020, the California Institute for Regenerative Medicine (CIRM) board expanded efforts related to the $5…
-
OraSures OMNIgene-ORAL kit included in EUA granted to P23 labs for at-home collection of saliva samples for SARS-CoV-2 test
On May 22, 2020, OraSure Technologies announced that its OMNIgene-ORAL saliva collection device (OM-505) was included in the…
-
Biotechnology | COVID-19 | Disease | Infectious Disease | Measles | Polio | Therapeutics | Vaccine | WHO
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupted routine vaccination efforts
On May 22, 2020, COVID 19 disrupted life-saving immunization services around the world, putting millions of children –…
-
Sinovac secured $15 million in funding to accelerate COVID-19 vaccine development
On May 22, 2020, Sinovac Biotech announced a transaction in which Advantech Capital and Vivo Capital have invested…
-
Abbott announced contract to supply millions of IgG lab-based antibody tests to UK government
On May 21, 2020, Abbott announced a government contract to supply millions of its laboratory-based IgG antibody tests…
-
Abbott released interim clinical study data on ID NOW COVID-19 rapid test showing strong agreement to lab-based molecular PCR tests
On May 21, 2020, Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care…
-
AstraZeneca advanced response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
On May 21, 2020, AstraZeneca announced it was advancing its response to address the unprecedented challenges of COVID-19,…
-
bioMerieux serology tests for SARS-CoV-2 on VIDAS received CE marking
On May 21, 2020, bioMerieux announced the CE marking of VIDAS® anti-SARS-CoV-2 serology tests to detect antibodies in people…
-
University of British Columbia researchers developed biodegradable medical mask for COVID-19
On May 21, 2020, the BioProducts Institute at the University of British Columbia announced it had designed a…
-
ADMA Biologics commenced collection of COVID-19 plasma from recovered patients
On May 21, 2020, ADMA Biologics announced it had commenced the collection of convalescent plasma through its wholly-owned…
-
Montefiore-Einstein Scientists lead two trials of leronlimab for treatment of severe lung inflammation in COVID-19 patients
On May 21, 2020, Montefiore Health System and Albert Einstein College of Medicine were the first sites in…
-
Vaxart announced selection of its oral COVID-19 vaccine lead candidate
On May 20, 2020, Vaxart announced it has entered into an agreement with Vaxart for the manufacture of…
-
ViralClear closed $10.8 million equity financing for development of COVID-19 broad-spectrum oral anti-viral candidate merimepodib
On May 20, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the closing of a $10.8 million…
-
Rapid Micro Biosystems raised $120 million to accelerate global expansion of contaminant testing platform for pharmaceutical and vaccine manufacturing
On May 20, 2020, Rapid Micro Biosystems announced a $120 million financing round, led by equity investment from…
-
INOVIO COVID-19 DNA vaccine INO-4800 demonstrated robust neutralizing antibody and T cell immune responses in preclinical models
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
-
Bharat Biotech and Thomas Jefferson University announced a promising vaccine candidate against COVID-19
On May 20, 2020, Bharat Biotech and Thomas Jefferson University of Philadelphia announced an exclusive deal to develop…
-
ARENSIA Begins Clinical Trial Program to Test Diffusion’s Lead Drug for the Treatment of Hospitalized COVID-19 Patients
On May 20, 2020, ARENSIA announced an agreement with Diffusion Pharmaceuticals to begin a clinical trial program to test…
-
Atossa Therapeutics announced in vitro testing results of COVID-19 drug inhibits SARS-CoV-2 infectivity
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossa’s proprietary COVID-19 drug…
-
Mammoth Biosciences collaborated with GSK to develop COVID-19 test using CRISPR-based platform
On May 20, 2020, Mammoth Biosciences announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use,…
-
Llama antibody engineered to block Coronavirus
On May 19, 2020, the National Institutes of Health (NIH) reported that researchers from the University of Texas,…
-
USC antibody study showed coronavirus infection more widespread in LA County than previously thought
On May 19, 2020, a University of Southern California (USC) study reported results from the first phase of…
-
Antibodies produced in response to one type of coronavirus don’t offer protection against the other, study suggests
On May 19, 2020, in a study published in Cell Reports, researchers at the University of Hong Kong…
-
Oragenics and Aragen Bioscience enter agreement to accelerate development of TerraCoV2, a SARS-CoV-2 (COVID 19) vaccine candidate
On May 19, 2020, Oragenics announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an…
-
Bio-Techne and Kantaro Biosciences announced partnership to develop and scale production of COVID-19 serology test
On May 19, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
